Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

High Proportion of PNH Type II Neutrophils, I.e. Relative Percentage ≥3%, Is Associated with Thrombosis in Patients Displaying a PNH Clone >1%: Evidence from Analysis of the 5-Year French Nation-Wide Multicenter Observational Study

Blood (2024) 144 (Supplement 1): 4080.

https://doi.org/10.1182/blood-2024-204647

Published: 2024

Journal Articles

Combination Chemotherapy in Patients with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN): First Results of a Prospective French Trial (LpDessai)

Blood (2023) 142 (Supplement 1): 1516.

https://doi.org/10.1182/blood-2023-173379

Published: 2023

Journal Articles

Persistence of PNH Clones over Time: Insights from the Mid-Term Analysis of the French Nation-Wide Multicenter Prospective Observational Study

Magali Le Garff-Tavernier, Agathe Pruvot Debliquis, PharmD, Thomas Boyer, MD, Jean-Philippe Vial, MD, Véronique Harrivel, MD, Anne-Catherine Lhoumeau, PhD PharmD, Marie-Christine Jacob, MD, Gerard Socie, MD PhD, Regis Peffault de Latour, MD PhD, Bernard Drenou, MD PhD, Orianne Wagner Ballon, MD PhD

Blood (2019) 134 (Supplement_1): 1218.

https://doi.org/10.1182/blood-2019-123415

Published: 2019

Journal Articles

Multicentric MFI30 Study: Standardization of CD30 Expression By Flow Cytometry in Non-Hodgkin Lymphoma

Agathe Pruvot Debliquis, pharmD, Lucile Baseggio, MD, Marie-Christine Jacob, Sabrina Bouyer, Franck Genevieve, MD PhD, Julien Guy, MD, Caroline Mayeur-Rousse, MD, Nicolas Chapuis, PharmD, PhD, Hind Bennani, Thomas Matthes, MD, Bernard Drenou

Blood (2018) 132 (Supplement 1): 2869.

https://doi.org/10.1182/blood-2018-99-115990

Published: 2018

Journal Articles

Dyserythropoiesis Evaluated By Red Score and Hepcidin/Ferritin Levels Predicts Response to Epoetin Zeta in Lower Risk MDS

Blood (2017) 130 (Supplement 1): 1705.

https://doi.org/10.1182/blood.V130.Suppl_1.1705.1705

Published: 2017

Journal Articles

Haploinsufficiency for NR3C1 , the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms

Blood (2016) 127 (24): 3040–3053.

https://doi.org/10.1182/blood-2015-09-671040

Published: 2016

Includes: Supplemental data

Journal Articles

Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCN

Eve Poret, Fanny Angelot Delettre, Sabeha Biichle, Anne Roogy, Louis Benazet, Maider Pagadoy, Chrystelle Vidal, Franck Leroux, Véronique Harrivel, Christophe Ferrand, PhD, Veronique Salaun, Zehaira Benseddik, Julien Guy, Marie Christine Jacob, Christophe Roumier, Jean Feuillard, Liliana Vila, Lucile Baseggio, Adriana Plesa, Christine Arnoulet, B Benet, Bernard Drenou, MD, Veronique Latger Cannard, Marie-Christine Bene, MD, Michel Ticchioni, Daniel Lusina, Valerie Bardet, Magalie LE Garff Tavernier, Elizabeth Macintyre, MD PhD, Vahid Asnafi, MDPhD, Maria Elena Noguera, Sabrina Bouyer, Carine Lecoq Lafon, Mikael Roussel, MD PhD, Fabrice Jardin, Francoise Solly, MD, Lydia Campos, MD PhD, Anne Galoisy, Anne Arnaud, Sylvie Daliphard, Franck Genevieve, MD PhD, Romaric Lacroix, Françoise Schillinger, Estelle Seilles, Delphine Binda, Eric Deconinck, Philippe Saas, PhD, Francine Garnache Ottou, PhD

Blood (2015) 126 (23): 3812.

https://doi.org/10.1182/blood.V126.23.3812.3812

Published: 2015

Journal Articles

Interest of Early Determination of Bone Marrow MRD by a Sensitive 6-Color Flow Cytometry in the Evaluation of Response: The Experience of the CLL2007FMP, An Intergroup Phase III Randomized Multicentric Trial Comparing Fludarabine Cyclophosphamide (FC) and Rituximab (FCR) Versus FC and MabCampath (FCCam) in Previously Untreated B-Chronic Lymphocytic Leukemia Patients

Remi Letestu, MD, Stéphane Leprêtre, MD, Christine Arnoulet, Pharm. D., Lucile Baseggio, Lydia Campos, MD, PhD, Bernard Chatelain, Bernard Drenou, MD, PhD, Marie-Christine Jacob, Eric Legac, Magali Le Garff-Tavernier, Nelly Robillard, Michel Ticchioni, Roselyne Delepine, Vincent Levy, MD, Sandrine Katsahian, Veronique Leblond, Florence Cymbalista, Pr, Pierre Feugier, MD, PhD

Blood (2011) 118 (21): 1797.

https://doi.org/10.1182/blood.V118.21.1797.1797

Published: 2011

Journal Articles

Identification of BDCA-2 and High Levels of CD123 Expression as Useful Markers for the Diagnosis of Plasmacytoid Dendritic Cell Leukemia.

Francine Garnache-Ottou, PhD, Marie-Christine Jacob, MD, Sabeha Biichle, BSc, Laurence Chaperot, PhD, Franck Trimoreau, MD, Joel Plumas, PhD, Pierre Tiberghien, MD, PhD, Philippe Saas, PhD, Jean Feuillard, MD, PhD

Blood (2005) 106 (11): 3269.

https://doi.org/10.1182/blood.V106.11.3269.3269

Published: 2005

Journal Articles

Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells

Blood (2005) 105 (3): 1256–1264.

https://doi.org/10.1182/blood-2004-06-2416

Published: 2005

Journal Articles

In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas

Olivier Manches, Gabrielle Lui, Laurence Chaperot, Rémy Gressin, Jean-Paul Molens, Marie-Christine Jacob, Jean-Jacques Sotto, Dominique Leroux, Jean-Claude Bensa, Joël Plumas

Blood (2003) 101 (3): 949–954.

https://doi.org/10.1182/blood-2002-02-0469

Published: 2003

Journal Articles

Clinical and biologic features of CD4 + CD56 + malignancies

Blood (2002) 99 (5): 1556–1563.

https://doi.org/10.1182/blood.V99.5.1556

Published: 2002

Journal Articles

Identification of a leukemic counterpart of the plasmacytoid dendritic cells

Laurence Chaperot, Nathalie Bendriss, Olivier Manches, Rémy Gressin, Marc Maynadie, Franck Trimoreau, Hubert Orfeuvre, Bernadette Corront, Jean Feuillard, Jean-Jacques Sotto, Jean-Claude Bensa, Francine Brière, Joël Plumas, Marie-Christine Jacob

Blood (2001) 97 (10): 3210–3217.

https://doi.org/10.1182/blood.V97.10.3210

Published: 2001

Journal Articles

Tumor B Cells From Non-Hodgkin's Lymphoma Are Resistant to CD95 (Fas/Apo-1)–Mediated Apoptosis

Joël Plumas, Marie-Christine Jacob, Laurence Chaperot, Jean-Paul Molens, Jean-Jacques Sotto, Jean-Claude Bensa

Blood (1998) 91 (8): 2875–2885.

https://doi.org/10.1182/blood.V91.8.2875.2875_2875_2885

Published: 1998

NARROW

High Proportion of PNH Type II Neutrophils, I.e. Relative Percentage ≥3%, Is Associated with Thrombosis in Patients Displaying a PNH Clone >1%: Evidence from Analysis of the 5-Year French Nation-Wide Multicenter Observational Study

Combination Chemotherapy in Patients with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN): First Results of a Prospective French Trial (LpDessai)

Persistence of PNH Clones over Time: Insights from the Mid-Term Analysis of the French Nation-Wide Multicenter Prospective Observational Study

Multicentric MFI30 Study: Standardization of CD30 Expression By Flow Cytometry in Non-Hodgkin Lymphoma

Dyserythropoiesis Evaluated By Red Score and Hepcidin/Ferritin Levels Predicts Response to Epoetin Zeta in Lower Risk MDS

Haploinsufficiency for NR3C1 , the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms

Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCN

Identification of BDCA-2 and High Levels of CD123 Expression as Useful Markers for the Diagnosis of Plasmacytoid Dendritic Cell Leukemia.

Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells

In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas

Clinical and biologic features of CD4 + CD56 + malignancies

Identification of a leukemic counterpart of the plasmacytoid dendritic cells

Tumor B Cells From Non-Hodgkin's Lymphoma Are Resistant to CD95 (Fas/Apo-1)–Mediated Apoptosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only